Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OrCel under review

This article was originally published in The Gray Sheet

Executive Summary

Ortec is raising funds for a planned September initiation of pivotal trials to support a diabetic foot ulcer indication for the wound care product. Meanwhile, FDA has accepted for review a modular PMA submission seeking market go-ahead for use of the collagen sponge for venous stasis leg ulcer treatment. Ortec is in talks with potential marketing partners and expects to ink a deal in time for the leg ulcer approval (1"The Gray Sheet" Feb. 16, 2004, p. 11)...

You may also be interested in...



Bilayered Collagen Matrix Would Treat Venous Leg Ulcer, Autograft Wounds

Ortec will launch its OrCel wound care product for three FDA-cleared indications once the cryopreserved tissue gains marketing approval in the late spring for venous leg ulcer treatment, the firm says

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.
UsernamePublicRestriction

Register

MT020059

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel